Albumin fusion proteins

Details Albumin fusion proteins Albumin fusion proteins

2006-08-08

2009-08-04

Nashed, Nashaat T (Department: 1656)

Chemistry: molecular biology and microbiology

Vector, per se

C435S069700, C435S252300, C435S254100, C435S365100, C536S023400

Reexamination Certificate

active

07569384

ABSTRACT:
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

REFERENCES:
patent: 5322930 (1994-06-01), Tamowski et al.
patent: 5545618 (1996-08-01), Buckley et al.
patent: 5612196 (1997-03-01), Becquart et al.
patent: 5637504 (1997-06-01), Hinchliffe et al.
patent: 5639642 (1997-06-01), Kjeldsen et al.
patent: 5646012 (1997-07-01), Fleer et al.
patent: 5665863 (1997-09-01), Yeh et al.
patent: 5667986 (1997-09-01), Goodey et al.
patent: 5668007 (1997-09-01), Spencer et al.
patent: 5726038 (1998-03-01), Christiansen et al.
patent: 5766883 (1998-06-01), Ballance et al.
patent: 5795746 (1998-08-01), Kjeldsen et al.
patent: 5876969 (1999-03-01), Fleer et al.
patent: 5912229 (1999-06-01), Thim et al.
patent: 5959075 (1999-09-01), Lok et al.
patent: 6087129 (2000-07-01), Newgard et al.
patent: 6110703 (2000-08-01), Egel-Mitani et al.
patent: 6110707 (2000-08-01), Newgard et al.
patent: 6165470 (2000-12-01), Becquart et al.
patent: 6191102 (2001-02-01), DiMarchi et al.
patent: 6214547 (2001-04-01), Kjeldsen et al.
patent: 6300065 (2001-10-01), Kieke et al.
patent: 6514500 (2003-02-01), Bridon et al.
patent: 6686179 (2004-02-01), Fleer et al.
patent: 7041478 (2006-05-01), Fleer et al.
patent: 7056701 (2006-06-01), Fleer et al.
patent: 7141547 (2006-11-01), Rosen et al.
patent: 7189690 (2007-03-01), Rosen et al.
patent: 7205280 (2007-04-01), Laskowitz et al.
patent: 7238660 (2007-07-01), Rosen et al.
patent: 7238667 (2007-07-01), Rosen et al.
patent: 7271149 (2007-09-01), Glaesner et al.
patent: 2001/0011071 (2001-08-01), Knudsen et al.
patent: 2004/0053370 (2004-03-01), Glaesner et al.
patent: 2004/0063635 (2004-04-01), Yu et al.
patent: 2006/0014254 (2006-01-01), Haseltine et al.
patent: 2007/0259815 (2007-11-01), Rosen et al.
patent: 2070781 (1991-02-01), None
patent: 0 591 524 (1994-04-01), None
patent: 0 624 195 (1994-11-01), None
patent: WO 90/01540 (1990-02-01), None
patent: WO 93/15199 (1993-08-01), None
patent: WO 94/03198 (1994-02-01), None
patent: WO 95/03405 (1995-02-01), None
patent: WO 95/17510 (1995-06-01), None
patent: WO 97/24445 (1997-07-01), None
patent: WO 97/26321 (1997-07-01), None
patent: WO 97/31943 (1997-09-01), None
patent: WO 98/11136 (1998-03-01), None
patent: WO 98/12344 (1998-03-01), None
patent: WO 98/20895 (1998-05-01), None
patent: WO 98/32867 (1998-07-01), None
patent: WO 99/43706 (1999-09-01), None
patent: WO 99/66054 (1999-12-01), None
patent: WO 01/77137 (2001-10-01), None
patent: WO 01/79271 (2001-10-01), None
patent: WO 01/79442 (2001-10-01), None
patent: WO 01/79443 (2001-10-01), None
patent: WO 02/46227 (2002-06-01), None
patent: WO 02/097038 (2002-12-01), None
patent: WO 03/030821 (2003-04-01), None
patent: WO 03/042354 (2003-05-01), None
patent: WO 03/059934 (2003-07-01), None
patent: WO 2005/000892 (2005-01-01), None
patent: WO 2005/003296 (2005-01-01), None
patent: WO 2005/077042 (2005-08-01), None
Dyer, C. A., et al., 1991, “Only multimers of a synthetic peptide mimic of human apolipoprotein E are biologically active”, The Journal of Biological Chemistry, vol. 266, No. 23, pp. 15009-15015.
Dyer, C. A., et al., 1991, “A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor”, The Journal of Biological Chemistry, vol. 266, No. 34, pp. 22803-22806.
Dyer, C.A., et al., 1995, “Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor”, Journal of Lipid Research, vol. 36, No. 1, pp. 80-88.
Sleep, D., et al., “Saccharomyces cerevisiaestrains that overexpress heterologous proteins”, Bio/Technology, vol. 9, pp. 183-187.
Adelhorst, K. et al., “Structure-Activity studies of glucagon-like peptide-1,” J. Biol. Chem. 269 (9): 6275-6278 (1994).
Gallwitz, B. et al., “Structure/activity characterization of glucagon-like peptide-1,” Eur. J. Biochem. 225: 1151-1156 (1994).
Hjorth, S.A. et al., “Glucagon and glucagons-like peptide-1: selective receptor recognition via distinct peptide epitopes,” J. Biol. Chem. 269 (48): 30121-30124 (1994).
Orskov, C. et al., “Complete sequences of glucagons-like peptide-1 from human and pig small intestine,” J. Biol. Chem. 264 (22): 12826-12829 (1989).
Parker, J.C. et al., “Structure-function analysis of a series of glucagons-like peptide-1 analogs,” J. Peptide Res. 52: 398-409 (1998).
Salvi et al., “Esterase-Like Activity of Human Serum Albumin Toward Prodrug Esters of Nicotinic Acid,” Drug Metabolism and Disposition, vol. 25, No. 4 (1997).
Urso, B. et al., “Differences in signaling properties of the cytoplasmis domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes,” J. Biol. Chem. 274(43): 30864-30873 (1999).
European Search Report for Appln. No. 02799966.3-1212-US024891, Jan. 20, 2005.
Yu, K. et al., “A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis,” J. Biological Chemistry, 274(2): 13733-13736 (1999).
International Search Report for International App. No. PCT/US02/40891 (WO 2003/060071 A3) (Apr. 21, 2003).
International Search Report for International App. No. PCT/US2002/040892 (WO 2003/059934 A3) (Feb. 26, 2004).
Supplementary European Search Report mailed Apr. 18, 2008, for EP Application No. 05722848.8 (9 pages).
Chinery et al., “A novel class of vector for yeast transformation,” Curr. Genet., 16: 21-25 (1989).
Sleep et al., “The Secretion of Human Serum Albumin from the YeastSaccharomyces cerevisiaeUsing Five Different Leader Sequences,” Bio/Technology, 8: 42-46 (1990).

Affiliated with

Also associated with

Rating

Albumin fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Albumin fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Albumin fusion proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4079853